---
title: Orasis Pharmaceuticals | Reshaping Vision Possibilities
description: Orasis Pharmaceuticals is an ophthalmic company and maker of Qlosi (pilocarpine HCl 0.4%), an FDA-approved prescription eye drop for presbyopia in adults.
image: https://orasis-pharma.com/hubfs/raw_assets/public/orasis-website/images/home-hero-bg.jpg
---
[Skip to content](https://orasis-pharma.com#main-content)
[ ](https://orasis-pharma.com)
- [ About ](https://orasis-pharma.com/about?hsLang=en)
#### [Company Overview Our mission, vision, and story](https://orasis-pharma.com/about?hsLang=en)
#### [Leadership Team Meet the executives driving our vision](https://orasis-pharma.com/leadership?hsLang=en)
#### [Board of Directors Guidance from industry leaders](https://orasis-pharma.com/board?hsLang=en)
#### [Investors Our partners in innovation](https://orasis-pharma.com/investors?hsLang=en)
- [ Qlosi ](https://orasis-pharma.com/qlosi?hsLang=en)
- [ Presbyopia ](https://orasis-pharma.com/presbyopia?hsLang=en)
- News
[Press Releases](https://orasis-pharma.com/press-releases?hsLang=en) [In the Media](https://orasis-pharma.com/in-the-media?hsLang=en)
- [Contact](https://orasis-pharma.com/contact?hsLang=en)
[Qlosi.com](https://qlosi.com?hsLang=en)
Orasis Pharmaceuticals®
# Delivering Solutions to Reshape Vision Possibilities
We are an ophthalmic pharmaceutical company delivering solutions to reshape vision possibilities.
[Learn About Us](https://orasis-pharma.com/about?hsLang=en) [Discover Qlosi](https://orasis-pharma.com/qlosi?hsLang=en)
Scroll
By providing solutions that empower patients to live their best lives, enabling eye care professionals to optimize care and creating opportunities for every Orasis employee to grow — we will inspire impact.
With deep expertise in eye care, and a willingness to take on challenges, we are committed to transforming the standard of care for near vision correction, with an initial focus on presbyopia, or age-related blurry near vision.
## Explore Orasis
### Discover Qlosi®
Available by prescription in the U.S., Qlosi® is transforming the standard of care for near vision correction.
[Discover Qlosi](https://orasis-pharma.com/qlosi?hsLang=en)
### Meet the Team
A collaborative team of industry executives and eye care professionals making a meaningful difference in the eyecare community.
[Meet the Team](https://orasis-pharma.com/leadership?hsLang=en)
Now Available 
Qlosi® (pilocarpine HCl ophthalmic solution) 0.4% is indicated for the treatment of presbyopia in adults. Available by prescription through BlinkRx.
[Learn More](https://orasis-pharma.com/qlosi?hsLang=en)
Latest News
## Press Releases
July 20, 2026
### Orasis Pharmaceuticals Doubles Down on Eye Care Professionals, Not Telehealth, as QLOSI® Refills Reach 49.1%
[Read More](https://orasis-pharma.com/press-releases/orasis-pharmaceuticals-doubles-down-on-eye-care-professionals-not-telehealth-as-qlosi-refills-reach-491?hsLang=en)
July 15, 2026
### Orasis Pharmaceuticals Announces Australia Submission of a New Drug Application for BESKA for the Treatment of Presbyopia
[Read More](https://orasis-pharma.com/press-releases/orasis-pharmaceuticals-announces-australia-submission-of-a-new-drug-application-for-beska-for-the-treatment-of-presbyopia?hsLang=en)
January 27, 2026
### New Data Demonstrate Qlosi™ Is Pupil Selective With Ciliary Muscle Movement No Different Than A Balanced Salt Solution (BSS) Control
[Read More](https://orasis-pharma.com/press-releases/new-data-demonstrate-qlosi-is-pupil-selective-with-ciliary-muscle-movement-no-different-than-a-balanced-salt-solution-bss-control?hsLang=en)
[View All Press Releases](https://orasis-pharma.com/press-releases?hsLang=en)
## Get in Touch
Ready to see what's possible? Contact us here.
[Contact Us](https://orasis-pharma.com/contact?hsLang=en)
### Qlosi® Important Safety Information
- Do not use Qlosi if you are allergic to any of the ingredients.
- Use caution when driving at night or performing hazardous activities in poor lighting. Qlosi may cause temporary dim or dark vision.
- Temporary problems when changing focus between near objects and distant objects may occur. Do not drive or operate machinery if your vision is not clear.
- Seek immediate medical care if you experience sudden onset of flashes of light, floaters or vision loss.
- If you wear contact lenses, they should be removed before using Qlosi. Wait 10 minutes after dosing before reinserting your contact lenses.
- Do not touch the tip of the vial to the eye or any other surface to prevent eye injury or contamination.
- If you use more than one eye medication, use each medication at least 5 minutes apart.
- The most common side effects reported with Qlosi in clinical trials were eye pain upon instillation and headache. These are not all of the possible side effects with Qlosi.
To report suspected side effects, contact Orasis Pharmaceuticals at 1-866-ORASIS-1 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch. Please see full Prescribing Information by [clicking here](https://orasis-pharma.com#).
[ ](https://orasis-pharma.com/?hsLang=en)
An ophthalmic pharmaceutical company delivering solutions to reshape vision possibilities.
#### Company
[Company Overview](https://orasis-pharma.com/about?hsLang=en) [Leadership Team](https://orasis-pharma.com/leadership?hsLang=en) [Board of Directors](https://orasis-pharma.com/board?hsLang=en) [Investors](https://orasis-pharma.com/investors?hsLang=en)
#### Product
[About Qlosi](https://orasis-pharma.com/qlosi?hsLang=en) [About Presbyopia](https://orasis-pharma.com/presbyopia?hsLang=en) [Qlosi.com](https://qlosi.com?hsLang=en)
#### News & Contact
[Press Releases](https://orasis-pharma.com/press-releases?hsLang=en) [In the Media](https://orasis-pharma.com/in-the-media?hsLang=en) [Contact Us](https://orasis-pharma.com/contact?hsLang=en) [info@orasis-pharma.com](mailto:info@orasis-pharma.com)
©2026 Orasis Pharmaceuticals, Inc. All Rights Reserved. QLOSI®, Orasis Pharmaceuticals, the Orasis Pharmaceuticals logo, and certain other trademarks herein are trademarks of Orasis Pharmaceuticals, Inc.
[Privacy Policy](https://orasis-pharma.com/privacy-policy?hsLang=en) [Terms of Service](https://orasis-pharma.com/terms-of-service?hsLang=en) [Health Data Privacy](https://orasis-pharma.com/health-data-privacy-policy?hsLang=en)
```json
{
"@context" : "https://schema.org",
"@id" : "https://www.orasis-pharma.com/#organization",
"@type" : "Organization",
"address" : {
"@type" : "PostalAddress",
"addressCountry" : "US",
"addressLocality" : "Ponte Vedra",
"addressRegion" : "FL",
"postalCode" : "32081",
"streetAddress" : "203 Fort Wade Rd., #140"
},
"contactPoint" : {
"@type" : "ContactPoint",
"contactType" : "customer service",
"email" : "info@orasis-pharma.com",
"telephone" : "+1-866-672-7471"
},
"description" : "Orasis Pharmaceuticals is an ophthalmic pharmaceutical company delivering solutions to reshape vision possibilities, developer of Qlosi (pilocarpine hydrochloride ophthalmic solution) 0.4% for the treatment of presbyopia in adults.",
"logo" : "https://qlosiecp.com/hubfs/HQ%20Only/Orasis_Pharmaceuticals_Logo_RGB.svg",
"name" : "Orasis Pharmaceuticals",
"sameAs" : [ "https://www.linkedin.com/company/orasis-pharmaceuticals/", "https://twitter.com/OrasisPharma" ],
"url" : "https://www.orasis-pharma.com/"
}
```
```json
{
"@context" : "https://schema.org",
"@id" : "https://www.orasis-pharma.com/#website",
"@type" : "WebSite",
"name" : "Orasis Pharmaceuticals",
"publisher" : {
"@id" : "https://www.orasis-pharma.com/#organization"
},
"url" : "https://www.orasis-pharma.com/"
}
```